Tema Oncology ETF (CANC) Holdings $24.48 +0.27 (+1.12%) As of 10:27 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 50 CANC HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$850.44+2.5%5.33%4,2102RHHBYRoche$39.14+0.4%5.19%80,4003RVMDRevolution Medicines$37.47+0.1%5.08%94,5784BMYBristol-Myers Squibb$48.38-0.3%4.68%49,3615AstraZeneca PLCN/A4.62%19,3576Novartis AGN/A4.43%24,1577EXELExelixis$37.37+1.6%4.24%71,4968BBIOBridgeBio Pharma$35.42+0.5%4.14%76,9669NUVLNuvalent$72.89+0.2%3.81%33,79410ZLABZai Lab$33.50-0.4%3.50%64,262 Get the Latest News and Ratings for CANC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter. 11Daiichi Sankyo Company, LimitedN/A3.42%80,80212GMABGenmab A/S$20.46+1.6%3.24%102,74913AMGNAmgen$279.16+0.5%3.11%6,16314MRUSMerus$42.98+2.7%2.98%45,55815MRKMerck & Co., Inc.$77.92-1.0%2.95%21,12316BPMCBlueprint Medicines$86.16+0.4%2.94%20,97217SMMTSummit Therapeutics$33.70+1.4%2.92%98,11118ONCBeigene$257.41+3.3%2.90%7,08319ACLXArcellx$63.01-1.0%2.86%28,45020LEGNLegend Biotech$34.300.0%2.86%52,00821Chugai Pharmaceutical Co., Ltd.N/A2.13%27,39622ABBVAbbVie$179.58+1.4%2.12%6,61323JANXJanux Therapeutics$31.51-0.4%2.03%45,93724GILDGilead Sciences$107.09+0.7%2.02%10,96425ARGXargenx$602.82+1.4%1.93%2,03226IDYAIDEAYA Biosciences$18.91+0.5%1.42%56,20427REGNRegeneron Pharmaceuticals$598.48+1.8%1.07%1,09228DAWNDay One Biopharmaceuticals$7.47+0.4%0.99%79,81829NRIXNurix Therapeutics$11.63+0.2%0.98%59,14630MREOMereo BioPharma Group$2.56-0.2%0.90%263,66331CGONCG Oncology$21.22+2.4%0.84%28,61232ELVNEnliven Therapeutics$17.57-1.2%0.76%23,64833IMCRImmunocore$29.66-0.5%0.72%15,42834GHGuardant Health$46.99+3.0%0.71%10,16035LNTHLantheus$101.74+0.5%0.68%4,32936ZYMEZymeworks$12.44-0.1%0.62%33,00137COGTCogent Biosciences$4.57+2.3%0.59%71,56338INCYIncyte$58.12+0.2%0.52%5,04239SDGRSchrödinger$26.27+3.2%0.51%16,45740CGEMCullinan Therapeutics$8.35-0.3%0.50%39,164Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why41REPLReplimune Group$8.96+1.5%0.48%37,52242ILMNIllumina$76.94+0.9%0.45%3,51343ARVNArvinas$9.13+0.7%0.41%36,24144SNDXSyndax Pharmaceuticals$13.35+2.7%0.41%21,16945ORICORIC Pharmaceuticals$5.25+1.5%0.34%40,93446RLAYRelay Therapeutics$3.05-2.1%0.31%89,11047AUTLAutolus Therapeutics$1.41-7.0%0.25%110,42848CELCCelcuity$11.05-0.2%0.23%15,61949RCUSArcus Biosciences$8.21+1.2%0.18%15,25150First American Treasury Obligations FundN/A0.02%9,343 Geographic ExposureUnited States84.0%Japan4.6%United Kingdom4.1%Switzerland4.1%Netherlands3.0%Currency ExposureUSD86.9%JPY4.6%GBP4.1%CHF4.1%Sector ExposureHealth Care98.2%Consumer Discretionary0.7%Information Technology0.7%Industry ExposureBiotechnology91.9%Pharmaceuticals5.0%Health Care Equipment & Supplies1.1%Diversified Consumer Services1.0%IT Services0.7%SubIndustry ExposureBiotechnology78.6%Pharmaceuticals11.7%Health Care Equipment0.7%Internet Services & Infrastructure0.7%Life Sciences Tools & Services0.4%Coupon Exposure4-60.2%Maturity Exposure15-200.2% Related Companies and Tools Related Companies Tema Electrification ETF Portfolio Companies Fidelity Disruptive Communications ETF Portfolio Companies Global X E-Commerce ETF Portfolio Companies Tradr 2X Long Innovation ETF Portfolio Companies RockCreek Global Equality ETF Portfolio Companies Global X U.S. Electrification ETF Portfolio Companies Invesco ESG NASDAQ 100 ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies Tema Cardiovascular and Metabolics ETF Portfolio Companies YieldMax Crypto Industry and Tech Portfolio Option Income ETF Portfolio Companies This page (NASDAQ:CANC) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CANC Stock Free CANC Stock Alerts